Proteinuria in a patient with Graves’ disease: Questions

[21] Nada R(1979)Nephrotic syndrome associated with methimazole therapy Arch Intern Med 139 236-39

[22] Suri D(2015)Membranous nephropathy: not just a disease for adults Pediatr Nephrol 30 31-274

[23] Gupta A(2012)KDIGO clinical practice guideline for glomerulonephritis Kidney Int Suppl 2 139-242

[24] Kohli HS(2012)Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence –based therapy Nephrol Dial Transplant 27 235-924

[25] Gupta KL(2002)Rituximab for idiopathic membranous nephropathy Lancet 360 923-866

[26] Jha V(2006)Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action Am J Transplant 6 859-657

[27] O’Regan JSC(1969)Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin Clin Exp Immunol 4 645-430

[28] Fong BS(2017)A proposal for a serology-based approach to membranous nephropathy J Am Soc Nephrol 28 421-919

[29] Kaplan JP(2008)Idiopathic membranous nephropathy: diagnosis and treatment Clin J Am Soc Nephrol 3 905-1205

[30] De Chadarevian N(2004)Idiopathic membranous nephropathy: definition and relevance of a partial remission Kidney Int 66 1199-42

[21] Nada R(1979)Nephrotic syndrome associated with methimazole therapy Arch Intern Med 139 236-39

[22] Suri D(2015)Membranous nephropathy: not just a disease for adults Pediatr Nephrol 30 31-274

[23] Gupta A(2012)KDIGO clinical practice guideline for glomerulonephritis Kidney Int Suppl 2 139-242

[24] Kohli HS(2012)Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence –based therapy Nephrol Dial Transplant 27 235-924

[25] Gupta KL(2002)Rituximab for idiopathic membranous nephropathy Lancet 360 923-866

[26] Jha V(2006)Rituximab, an anti-CD20 monoclonal antibody: history and mechanism of action Am J Transplant 6 859-657

[27] O’Regan JSC(1969)Perpetuation of autoimmune thyroiditis and production of secondary renal lesions following periodic injections of aqueous preparations of altered thyroglobulin Clin Exp Immunol 4 645-430

[28] Fong BS(2017)A proposal for a serology-based approach to membranous nephropathy J Am Soc Nephrol 28 421-919

[29] Kaplan JP(2008)Idiopathic membranous nephropathy: diagnosis and treatment Clin J Am Soc Nephrol 3 905-1205

[30] De Chadarevian N(2004)Idiopathic membranous nephropathy: definition and relevance of a partial remission Kidney Int 66 1199-42